FDA commissioner pledges to investigate mifepristone

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.). “As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy,” Makary wrote to Hawley. “As the Commissioner of...